All In Biotech

Drug Trial Radar · NCT06233474

Study of Intra-articular Allocetra in Knee Osteoarthritis

A Phase 1/2a Randomized, Double-Blind Placebo-controlled Study of Intra-articular Allocetra in Knee Osteoarthritis

Last checked: Nov 19, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 134 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

134

Actual

Start

Jan 26, 2024

Primary completion

Mar 15, 2026

Study completion Oct 15, 2026

Sponsor

Lead sponsor
Enlivex Therapeutics Ltd.Industry
Sponsor type
Industry
Collaborators
Nordic Bioscience Clinical Development
First posted
Jan 31, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 45 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a double blind, randomized,multi-center study to evaluate the safety and efficacy of intra-articular administration of Allocetra compared to placebo in patients with symptomatic knee osteoarthritis.

Conditions

  • Osteoarthritis, Knee

Interventions

  • AllocetraDrug

    Allocetra-OTS is a cell-based therapy consisting of non-HLA-matched allogeneic peripheral blood mononuclear cells, induced to an apoptotic stable state

  • PlaceboOther

    The control used in this study will be placebo. Placebo solution containing all excipients except for the Allocetra cells.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Treatment-emergent adverse events and Serious adverse events following Allocetra-OTS injectionTime frame: 7 months following Day 0

Locations

12 sites in 3 countries. Site status is shown where the registry gives one.

  • Sanos Clinic Nordjylland

    Gandrup, Denmark

  • Sanos Clinic Herlev

    Herlev, Denmark

  • Sanos Clinic Syddanmark

    Vejle, Denmark

  • Barzilai Medical Center

    Ashkelon, Israel

  • Rambam Medical Center

    Haifa, Israel

  • Hasharon Medical Center

    Petah Tikva, Israel

  • Sheba Medical Center

    Ramat Gan, Israel

  • Kaplan Medical Center

    Rehovot, Israel

  • Ichilov - Tel Aviv Sourasky Medical Center

    Tel Aviv, Israel

  • IMSP Institutul de Cardiologie

    Chisinau, Moldova

  • Spitalul Clininc Republican "T. Mosneaga"

    Chisinau, Moldova

  • IMSP Sptalul Clinic Municipal "Sfanta Treime"

    Chisinau, Moldova

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.